Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MOTREM in Septic Shock
NCT03158948Phase 2Completed
- Sponsor
- Inotrem
- Start
- Jul 2017
- Primary completion
- Jun 2018
- Modality
- Peptides
- Countries
- 4
01
Overview
A Phase 2 trial of nangibotide in septic shock, sponsored by Inotrem. Started Jul 2017; status: completed.
02
Drugs
nangibotide
03
Conditions
septic shock
Beyond the preview
Go deeper on NCT03158948.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03158948.